Friday, July 10, 2020 9:14:58 PM
References:
Bruce Patterson MD did the research for the eIND patients which lead to new discoveries about how COVID19 attacks the body and how LeronLimab quiets the immune system response that overwhelms the lungs.
The link is to the paper that is currently in the peer review process before being approved for publication. Principal Author Bruce Patterson
https://www.medrxiv.org/content/10.1101/2020.05.02.20084673v1.full.pdf
The next link is an update from the Montefiore Medical Center, NY who is participating in the LeronLimab drug trials.
https://www.montefiore.org/body.cfm?id=1738&action=detail&ref=1746
Exert:
“By calming the overactive immune systems of these patients, leronlimab halted the inflammation and blood clotting that are so damaging to the lungs, liver and kidneys of severely ill COVID-19 patients,” said Dr. Seethamraju. All 10 patients had extremely high blood levels of CCL5, which are inflammatory molecules known as cytokines. This is why the extreme inflammatory response is known as the “cytokine storm.”
The next link is the best description I've found on the time line and attack of the stock CYDY on June 30th
Misleading Headline on CydoDyn (CYDY) Triggers Algo Selling
https://emerginggrowth.com/misleading-headline-on-cydodyn-cydy-triggers-algo-selling/
Exert from the first paragraph;
Top short seller Andrew Left from Citron Research facilitated a bear raid led by Tim Sykes and his army of smaller short sellers, and eventually Adam Feuerstein chimed in toward the close. In 16 minutes the CytoDyn Inc. (OTCMKTS: CYDY) stock dropped from $9.64 to $4.65 losing close to $2.6 billion of market cap.
The article is not long and it's worth a read.
The last link is to the petition I've contributed to in an effort to encourage SEC to investigate the (illegal) short selling.
https://www.change.org/p/u-s-securities-and-exchange-commission-sec-enforcement-to-investigate-andrew-left-of-citron-research?cs_tk=AgcU74QF3zonQ5zgA18AAXicyyvNyQEABF8BvN9z60HVExU3wLxXtEFQmbc%3D&utm_campaign=6c263fc7107c4dd0acd3159e4e244d84&utm_content=initial_v0_0_3&utm_medium=email&utm_source=promotion_completion&utm_term=cs
Sorry for the really long link but I'm not sure how to shorten it (perhaps someone else does?) and if you haven't signed it yet, consider doing so.
Chuckles post 90022 has the link to the Citron "Research" report. I hesitate to post it direclty as the shortened version of the link doesn't copy.
Recent CYDY News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2024 02:30:20 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/01/2024 10:16:47 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/01/2024 10:15:34 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 02/22/2024 10:16:11 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/22/2024 05:15:08 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 02:00:24 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/12/2024 10:31:57 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/29/2024 10:22:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/29/2024 01:40:14 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/19/2024 10:15:35 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/16/2024 10:16:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:04:57 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:04:20 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:02:59 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:02:30 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:01:55 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:01:14 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/22/2023 10:15:19 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM